Watch Out for Bleeding in These Cancer Patients on Extended Anticoagulation

(MedPage Today) — ORLANDO — Researchers identified four predictors of clinically relevant bleeding in patients receiving extended anticoagulation with apixaban (Eliquis) for cancer-associated venous thromboembolism (VTE).
Over a median follow…

Source link : https://www.medpagetoday.com/meetingcoverage/ashhematology/118933

Author :

Publish date : 2025-12-10 18:27:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

Watch Out for Bleeding in These Cancer Patients on Extended Anticoagulation

Test your brain on these mind-bending scientific riddles

SCOTUS May Impede State Investigations Into Crisis Pregnancy Centers

Related Posts

One GLP-1 Drug May Be Better Than Rivals for Glaucoma Risk

Doctor strike during flu outbreak would be ‘beyond belief’, says Starmer

Why are sperm donors having hundreds of children?

Survival Is Possible With Resuscitation in Some Extremely Premature Infants

CDC Says Kids’ COVID Shots Reduced Emergency Department Visits

Anticoagulant Reversal Drug Pulled From U.S. Market

One GLP-1 Drug May Be Better Than Rivals for Glaucoma Risk

Doctor strike during flu outbreak would be ‘beyond belief’, says Starmer

Why are sperm donors having hundreds of children?

Survival Is Possible With Resuscitation in Some Extremely Premature Infants

CDC Says Kids’ COVID Shots Reduced Emergency Department Visits

Anticoagulant Reversal Drug Pulled From U.S. Market

Study Makes the Case for Replacing Annual Breast Cancer Screening

Some Health Plans Automatically Downcode Office Visit Claims

Categories

Archives